6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge

Closed Pre-Solicitation Posted

Not the latest version. See the latest special notice from .

Solicitation number
36C77026Q0061
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Department of Veterans Affairs Multiple Locations Nationwide

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs, Consolidated Mail Outpatient Pharmacy (CMOP), is seeking to identify domestic pharmaceutical manufacturers through this Request for Information (RFI) for market research and procurement planning purposes. The VA operates seven CMOP sites across the United States that mail approximately 450,000 prescriptions daily to Veterans, supplementing their Prime Vendor contract through Open Market purchases. This RFI targets both small and large domestic businesses capable of manufacturing over 50 different pharmaceutical and medical-surgical items, with preference given to Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Businesses (VOSB). Interested manufacturers must submit a capability statement by March 15, 2026, at 4:30 pm CT that includes company information, product details, manufacturing capabilities, FDA-approved NDC numbers, production capacity, and compliance certifications. The evaluation will consider manufacturers' domestic production facilities, socioeconomic status, stockout frequency, and typical replenishment timelines. This RFI does not constitute a binding solicitation and does not guarantee contract award.

This opportunity carries no set-aside designation and does not identify any incumbent contractors or current award values, as this is a market research phase rather than an active solicitation. The RFI addresses a broad range of pharmaceutical products treating conditions including osteoporosis, alcoholism, dry eyes, diabetes, hypertension, and depression, among others. No funds have been authorized, appropriated, or received for this effort at this time. The response deadline is March 16, 2026, providing potential offerors approximately three months to gather and submit their capability information. While specific award values are not disclosed in this pre-solicitation notice, the scope reflects the VA's significant ongoing pharmaceutical procurement needs to support Veteran healthcare across its national CMOP network.

Notice text

36C77026Q0061

Request for Information (RFI):

Domestic Pharmaceutical Manufacturing 36C77026Q0061

1. Overview

The Department of Veterans Affairs (VA), Consolidated Mail Outpatient Pharmacy (CMOP) operates seven sites across the United States, supporting the daily mailout of approximately 450,000 prescriptions to Veterans. While the majority of these prescriptions are fulfilled through the Prime Vendor contract, CMOP supplements its supply through Open Market (OM) purchases when necessary, through solicitations that get published to the System for Award Management (SAM) website, similar to how this RFI is being published.

To support these OM requirements, the Government has an ongoing need to identify pharmaceutical end items manufactured, processed, or produced by domestic small and large businesses. This RFI is issued solely for market research and procurement planning purposes and does not constitute a Request for Quote (RFQ) or Request for Proposal (RFP). This notice shall not be construed as a commitment by the Government to ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. This request does not constitute a solicitation for proposals or quotes or the authority to enter into negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort. Related details can be found in section six (6) regarding the nature of this RFI.

2. Purpose

The purpose of this RFI is to:

Identify domestic small and large business pharmaceutical manufacturers with efficient production capabilities related to FAR Part 12 Acquisition of Commercial Products and Commercials Services in combination with FAR Part 25 Foreign Acquisition procedures.

Gather information on manufacturers of pharmaceuticals and ancillary items related to CMOP s OM purchases.

Promote early exchanges of information in accordance with Federal Acquisition Regulation (FAR) Overhaul Part 15.101, to improve mutual understanding of Government needs and industry capabilities.

Deeper Insight into Small Business type considerations in manufacturing to include all socio-economic considerations with the highest interest in Service-Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Business (VOSB) Manufacturers.

3. Scope

The overall intent of the RFI is to provide outreach within the designated NAICS codes:

325412 - Pharmaceutical Preparation Manufacturing

325413 - In-Vitro Diagnostic Substance Manufacturing

The list presented below is not exhaustive of pharmaceutical and medical surgical items that may be required in Fiscal Year (FY) 26 and is subject to be updated periodically as our requirements change.

CMOP is seeking information from both small and large domestic manufacturers capable of providing the following items to support CMOP s OM needs:

Station item #

Pharmaceutical Description

Treatment

16822

ABALOPARATIDE 80MCG/O.04ML PEN 156ML

Used for those who suffer from high risk osteoporosis

10834

ACAMPROSATE CA 333MG TAB

Used to help overcome alcoholism

18491

ARMODAFINIL 250MGTAB

Used to treat excessive sleepiness (narcolepsy)

12784

ARMODAFINIL 50MG TAB

Used to treat excessive sleepiness (narcolepsy)

2955

ARTIFICIAL SALIVA ORAL SPRAY

Used to treat dry mouth or bad breath

13125

BREAST MILK, STORAGE BAGS, 100ct

Used to store breast milk

15663

BRIMONIDINE TARTRATE 0.025% OPH SOLN

Used to lower pressure inside the eye

12679

CALCIUM 500MG/VITAMIN D 500UNIT CHEW TAB

Used to treat low calcium and vitamin D levels

13707

CARBOXYMETHYLCELLULOSE NA 0.25% OPH SOLN 15ML

Used to treat dry eyes

XV066

CATH SET, INTERMIT 14FR H#96144

Used to drain the bladder

XT265

CATH,EXTERNAL EXTENDED WEAR MED H#9207

Used to drain the bladder

C0820

CLINDAMYCIN P04 1% TOP SWAB

Used to treat acne lesions

C0482

CLOMIPHENE CITRATE 50MG TAB

Used to induce ovulation (egg production)

C0731

COAL TAR 2% SHAMPOO

Used to treat eczema, psoriasis, dermatitis, and other skin disorders

C0609

COLESTIPOL HCL 1GM TAB

Used to lower high cholesterol levels in the blood

D0025

DESONIDE 0.05% CREAM,TOP

Used to relieve redness, itching and other discomfort caused by skin conditions

D0938

DORZOLAMIDE 22.3/TIMOLOL6.8MG/ML PF OPH

used to treat increased pressure in the eye

D0828

DORZOLAMIDE 22.3_TIMOLOL6.8MG_ML OPH SOL

Used to treat increased pressure in the eye

XH825

DRESSING,DRAWTEX 4IN X 4IN

Treatment in wound care

D1217

DROSPIRENONE 4MG TAB,28

Used to prevent ovulation and pregnancy

D0922

DULOXETINE HCL 20MG EC CAP

Used to treat depression and anxiety

D0929

DULOXETINE HCL 30MG EC CAP

Used to treat depression and anxiety

D0924

DULOXETINE HCL 60MG EC CAP

Used to treat depression and anxiety

XJ196

ELECTRODE PAD EARCLIP AS#EEP

Used with an electrotherapy stimulator for the treat anxiety, depression, and insomnia

E0811

ESOMEPRAZOLE 20MG (BASE) EC CAP

Used for the treatment of erosive esophagitis

E0301

EYELID CLEANSER,EYE SCRUB PAD

Used to maintain ocular surface health for patients with blepharitis, MGD, and demodex infections

XK812

FEMALE CONDOM,INTERNAL

Used to help prevent pregnancy and reduce the risk of sexually transmitted diseases

F0355

FENOFIBRATE 145MG TAB

Used to reduce elevated low-density lipoprotein cholesterol

F0354

FENOFIBRATE 48MG TAB

Used to reduce elevated low-density lipoprotein cholesterol

F0423

FESOTERODINE FUMARATE 4MG SA TAB

Used for the treatment of overactive bladder

F0135

FOSINOPRIL NA 40MG TAB 90CT

Used for the treatment of hypertension

G0257

GALANTAMINE HYDROBROMIDE 8MG SA CAP

Treatment of mild to moderate dementia of the Alzheimer's

G0194

GLIPIZIDE 2.5MG SA TAB

Used to improve glycemic control in adults with diabetes

H0066

HYDROCORTISONE ACETATE 25MG RTL SUPP

Used to treat hemorrhoids

I0004

IBUPROFEN 400MG TAB

Used to treat pain, fever, and inflammation

I0005

IBUPROFEN 600MG TAB

Used to treat pain, fever, and inflammation

I0006

IBUPROFEN 800MG TAB

Used to treat pain, fever, and inflammation

J0040

JASMIEL TAB,28

Used to prevent pregnancy

L0329

LANSOPRAZOLE 15MG SA DISINTEGRATING TAB

Treatment of ulcers

L0330

LANSOPRAZOLE 30MG SA DISINTEGRATING TAB

Treatment of ulcers

XZ156

LEG BAG COMBINATION PK H#9349 LATEX FREE

Used to collect urine through a catheter drain tube

L0780

LEVODOPA 42MG INHL CAP

Used in the treatment of Parkinson disease as a dopamine replacement

LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB

used to treat different types of bacterial infections.

M1295

METFORMIN (EQV-FORTAMET) 1000MG SA TAB

Management of type 2 diabetes

M0103

MINOCYCLINE HCL 50MG CAP

Used to treat infections cased by bacteria

N0567

NEBIVOLOL 5MG TAB

Used to treat high blood pressure

XZ173

ONE TOUCH ULTRA (GLUCOSE) TEST STRIPS 50CT & 100CT

Used to test blood glucose levels in managing type 1 & 2 diabetes

XH026

PAD,NURSING DISPOSABLE

Used on breast feeding mothers to absorb any milk that may leak between feedings

P0535

PIOGLITAZONE HCL 15MG TAB

Management of type 2 diabetes

P0536

PIOGLITAZONE HCL 30MG TAB

Management of type 2 diabetes

P0537

PIOGLITAZONE HCL 45MG TAB

Management of type 2 diabetes

P0110

PREDNISONE 1MG TAB 1000CT

Corticosteriod used on the immune system to help relieve swelling, redness, itching, and allergic reactions

P0156

PROPRANOLOL HCL 60MG SA CAP - 33030

used to treat high blood pressure

P0175

PYRIDOSTIGMINE BROMIDE 60MG TAB

Used to treat myasthenia gravis muscle weakness

R0233

RESOURCE BENEPROTEIN PWDR,227GM

used to supply protein needed to help maintain muscle. For patients that can t eat food.

XJ330

SET,INFUSION AUTOSOFT XC TANDEM #1001680

Used to manage diabetes by delivering insulin from a pump to the body

XJ441

SET,INFUSION AUTOSOFT XC TANDEM #1001729

Used to manage diabetes by delivering insulin from a pump to the body

S0578

SEVELAMER CARBONATE 800MG TAB

For the control of serum phosphorus in adults with chronic kidney disease on dialysis

S0167

SODIUM CHLORIDE 2% OPH SOLN

Used to reduce surface corneal swelling of the eye

S0174

SUMATRIPTAN 6MG_0.5ML INJ SYRINGE 0.5ML

Used for treatment of migraines

U0004

UREA 40% CREAM

Used to treat dry/rough skin conditions and some nail problems

Z0005

ZINC OXIDE 20% OINT (60GM & 464GM)

Used to treat or prevet skin irritation

Z0067

ZOLPIDEM TARTRATE 12.5MG SA TAB

Used to treat insomnia

4. Submission Guidelines

If your company manufactures pharmaceuticals that are not listed above and are produced domestically in accordance with (IAW) FAR Part 25.001(c), please provide the following information:

Company Information:

Name, physical address, and point of contact

Physical address of domestic manufacturing facility

Socioeconomic status (e.g., SDVOSB, VOSB, 8(a), etc.) to include both large and small business types

Business size and SAM UEI Number

Product Information:

List of domestically manufactured pharmaceuticals

FDA-approved NDC numbers

Treatment usage of each pharmaceutical

Authorized distributors

Average cost for common prescription quantities

Operational Capability:

Manufacturing facility production capacity (volume)

Frequency of stockouts in the past 12 months

Typical replenishment timelines

Commercial entities where the items have been sold to for ultimate large volume dispensing.

Contracting Information:

GSA/FSS/NAC contract numbers (if applicable)

Suggested alternative NAICS or PSC codes, if more appropriate

Compliance:

Any manufacturer responding to this announcement must be able to show their capability to comply with:

Ability to meet federal, state, and local regulations

Capacity to support all seven CMOP sites if needed

Interested manufacturers are reminded that in accordance with FAR 4.12, prospective contractors shall complete electronic annual representations and certifications in conjunction with FAR 4.11 required registration in the System for Award Management (SAM) database prior to award of a contract.

5. Response Instructions:

If you believe you are capable of meeting the requirement, please provide a complete capability statement and response by March 15, 2026, at 4:30 pm CT to:

Michael McAlhaney

Email: michael.mcalhaney@va.gov

Tresanna Tacia

Email: tresanna.tacia@va.gov

Subject Line of Email: Must start with the 1) RFI Number 36C77026Q0061 followed by the 2) generic pharmaceutical name. The proprietary name should only be used when there are no FDA approved generic options.

Use the Excel Spreadsheet inputs as identified as Manufacturer Inputs_Excel as part of a complete submission.

6. Important Notice

PLEASE NOTE: This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Respondents are solely responsible for all expenses associated with responding to this RFI. The Government does not intend to award a contract on the basis of the RFI or otherwise pay for the information requested. Responses will be treated as information only and not as a proposal.

Files

File Type Posted
36C77026Q0061_1.docx DOCX document
P02_Sources Sought_Attch1_Manufacturer Inputs_Excel.xlsx XLSX spreadsheet

Notice history

Notice Type Posted
6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge Amendment 0001 Latest special notice Special Notice
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312) Department of Veterans Affairs Cmop Ladson (Charleston 766 A) Ladson, South Carolina 29456, United States · NAICS 325412 Veterans Integrated Service Network 15 No set-aside
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside
6505--Department of Veterans Affairs Pharmaceutical Industry Day NAICS 325412 Veterans Integrated Service Network 12 No set-aside
Tucson CMOP Shipping Box/Coolers Tucson, Arizona 85706, United States · NAICS 322220 Veterans Integrated Service Network 15 No set-aside
6505--VA Long Beach Pylarify NAICS 325412 Veterans Integrated Service Network 22 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity